Axsome Therapeutics Inc. | Ownership
Companies that own Axsome Therapeutics Inc.
Fidelity Management & Research Co.
981,950
3.74%
0
0%
06/30/2018
Royce & Associates LP
888,400
3.38%
-67,600
0.02%
06/30/2018
The Vanguard Group, Inc.
575,900
2.19%
47,151
0%
06/30/2018
1919 Investment Counsel LLC
404,145
1.54%
0
0.02%
06/30/2018
Alethea Capital Management LLC
270,823
1.03%
154,323
1.5%
06/30/2018
Sio Capital Management LLC
193,290
0.74%
0
0.37%
06/30/2018
Opus Point Partners Management LLC
133,500
0.51%
0
0.91%
06/30/2018
Geode Capital Management LLC
94,205
0.36%
0
0%
06/30/2018
Bridgeway Capital Management, Inc.
88,000
0.34%
0
0%
06/30/2018
JPMorgan Securities LLC (Investment Management)
81,678
0.31%
59,301
0%
06/30/2018
| Address |
200 Broadway
New York New York 10038
United States
|
|
Employees
|
- |
| Website |
http://www.axsome.com |
| Updated |
07/08/2019 |
| Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies for the management of central nervous system disorders. Its product candidates include AXS-02 and AXS-06 which are developing for multiple indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY. |
